Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Pesampator with Itraconazole in Healthy Adults
NCT02341482Phase 1Completed
- Sponsor
- Biogen
- Start
- Feb 2015
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of pesampator in schizophrenia and cognitive impairment, sponsored by Biogen. Primary endpoints: Area Under the Concentration-Time Profile From Time 0 to Time Tau at Day 17 and Maximum Observed Plasma Concentration at Day 17. Started Feb 2015; status: completed.
02
Drugs
pesampator
03
Conditions
schizophreniacognitive impairment
Beyond the preview
Go deeper on NCT02341482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02341482.